Emerging from the UK, retatrutide, a novel peptide , is creating considerable interest within the scientific community regarding its potential for body management . This dual GIP and GLP-1 agent agonist seems to provide a significant benefit over current therapies, showing positive results in preliminary clinical trials . Researchers believe its un